Topical Cannabidiol in the Treatment of Digital Ulcers in Patients with Scleroderma: Comparative Analysis and Literature Review
- PMID: 36537770
- PMCID: PMC9788924
- DOI: 10.1097/01.ASW.0000891856.08360.61
Topical Cannabidiol in the Treatment of Digital Ulcers in Patients with Scleroderma: Comparative Analysis and Literature Review
Abstract
Objective: To explore the effect of topical cannabidiol (CBD) in treating digital ulcers in patients with systemic sclerosis (SSc).
Methods: In total, 45 patients with SSc who had digital ulcers were consecutively enrolled between January 2019 and December 2019. Of the participants, 25 were treated with CBD during surgical debridement and 20 were treated with standard local therapy. A numeric rating scale for pain and Health Assessment Questionnaire Disability Index were administered at the baseline and at the end of treatment.
Results: Local treatment with CBD was significantly associated with lower pain scores, higher health assessment scores, and an increase in participants' total hours of sleep. Patients in the control group more frequently required additional analgesic therapy.
Conclusions: Topical CBD may be a valuable tool to treat pain related to digital ulcers in patients with SSc.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Figures
References
-
- Giuggioli D, Manfredi A, Lumetti F, Colaci M, Ferri C. Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. Autoimmunity Rev 2018;17(2):155–64. - PubMed
-
- Maida V, Biasi SA. “Less pain with more gain”—Managing wound-related pain with cannabis-based medicines. Wound Repair Regen 2021;29(2):338–41. - PubMed
-
- Giuggioli D, Manfredi A, Vacchi C, Sebastiani M, Spinella A, Ferri C. Procedural pain management in the treatment of scleroderma digital ulcers. Clin Exp Rheumatol 2015;33(1):5–10. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical